Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection

被引:70
作者
Desem, N [1 ]
Jones, SL [1 ]
机构
[1] CSL Ltd, Biosci Div, Parkville, Vic 3052, Australia
关键词
D O I
10.1128/CDLI.5.4.531-536.1998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A sensitive two-step simultaneous enzyme immunoassay (EIA) for human gamma interferon (IFN-gamma) has been developed and used as an in vitro test for human tuberculosis (TB) in comparison with tuberculin skin testing. The EIA was shown to be highly sensitive, detecting less than 0.5 IU of recombinant human IPN-gamma per mi within a linear detection range of 0.5 to 150 IU/ml, The assay was highly reproducible and specific for native IFN-gamma. In addition, the assay detected chimpanzee, orangutan, gibbon, and squirrel monkey IFN-gamma s. Cross-reactions with other human cytokines or with IFN-gamma s derived from mice, cattle, or Old World monkeys were not evident, The assay was used to detect TB infection by incubating whole blood overnight with human, avian, and bovine tuberculin purified protein derivatives (PPDs), as well as positive (mitogen)- and negative-control preparations. The levels of IFN-gamma in plasma supernatants were then determined. Blood from 10 tuberculin skin test-positive individuals responded predominantly to the human tuberculin PPD antigen and to a lesser extent to bovine and avian PPD antigens, By contrast, blood from 10 skin test negative individuals showed minimal responses or no response to any of the tuberculin PPDs, Detectable levels of IFN-gamma were present in all blood samples stimulated with mitogen, In vivo tuberculin reactivity was correlated with IFN-gamma responsiveness in vitro. These results support the further study of the blood culture-IFN-gamma EIA system as an alternative to skin testing for the detection of human TB infection.
引用
收藏
页码:531 / 536
页数:6
相关论文
共 34 条
[11]   MONOCLONAL-ANTIBODIES TO HUMAN INTERFERON-GAMMA .2. ANTIBODIES WITH NEUTRALIZING ACTIVITY [J].
ICHIMORI, Y ;
SUZUKI, N ;
KITADA, C ;
TSUKAMOTO, K .
HYBRIDOMA, 1987, 6 (02) :173-181
[12]   REMOVAL OF FALSE-POSITIVE REACTIONS FROM PLASMA IN AN ENZYME-IMMUNOASSAY FOR BOVINE INTERFERON-GAMMA [J].
JONES, SL ;
COX, JC ;
SHEPHERD, JM ;
ROTHEL, JS ;
WOOD, PR ;
RADFORD, AJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 155 (02) :233-240
[13]  
KANSAL R, 1991, MED MICROBIOL IMMUN, V180, P73, DOI 10.1007/BF00193848
[14]  
Kaufmann SHE, 1996, T-CELL SUBSETS AND CYTOKINES INTERPLAY IN INFECTIOUS DISEASES, P169
[15]  
KRICKA LJ, 1990, CLIN CHEM, V36, P892
[16]  
LENZINI L, 1977, CLIN EXP IMMUNOL, V27, P230
[17]   SERUM LEVELS OF TUMOR-NECROSIS-FACTOR, INTERLEUKIN-2 RECEPTOR, AND INTERFERON-GAMMA IN KAWASAKI-DISEASE INVOLVED CORONARY-ARTERY LESIONS [J].
MATSUBARA, T ;
FURUKAWA, S ;
YABUTA, K .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 56 (01) :29-36
[18]   THE BOOSTER EFFECT IN 2-STEP TUBERCULIN TESTING AMONG YOUNG-ADULTS IN MONTREAL [J].
MENZIES, R ;
VISSANDJEE, B ;
ROCHER, I ;
STGERMAIN, Y .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (03) :190-198
[19]   INTERFERON RESPONSES OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM NORMAL AND LEUKEMIC CHILDREN [J].
MOHAMMED, GS ;
TAYLOR, CE ;
DICKINSON, AM ;
CRAFT, AW ;
KERNAHAN, J ;
REID, MM ;
PROCTOR, SJ ;
TOMS, GL .
BRITISH JOURNAL OF HAEMATOLOGY, 1986, 64 (04) :789-798
[20]   PATIENTS AT RISK FOR AIDS-RELATED OPPORTUNISTIC INFECTIONS - CLINICAL MANIFESTATIONS AND IMPAIRED GAMMA INTERFERON-PRODUCTION [J].
MURRAY, HW ;
HILLMAN, JK ;
RUBIN, BY ;
KELLY, CD ;
JACOBS, JL ;
TYLER, LW ;
DONELLY, DM ;
CARRIERO, SM ;
GODBOLD, JH ;
ROBERTS, RB .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (24) :1504-1510